Abstract
Background
Polyamine biosynthesis is controlled primarily by ornithine decarboxylase (ODC) and S‐adenosylmethionine decarboxylase (AdoMetDC). Polyamine concentrations are elevated in colorectal cancer. Depletion of polyamine content in colorectal cancer by chemotherapy is related to tumor regression and impaired tumorigenicity. The current study evaluates the therapeutic effects of antisense ODC and AdoMetDC sequences on colorectal cancer in vitro and in vivo.
Methods
Antisense ODC and AdoMetDC sequences were cloned into an adenoviral vector (Ad‐ODC‐AdoMetDCas). The human colon cancer cell lines, HT‐29 and Caco‐2, were infected with Ad‐ODC‐AdoMetDCas as well as with control vector. Viable cell counting, determination of polyamine concentrations, cell cycle analysis, and Matrigel invasion assays were performed in order to assess properties of tumor growth and invasiveness. Furthermore, the antitumor effects of Ad‐ODC‐AdoMetDCas were also evaluated in vivo in a nude mouse tumor model.
Results
Our study demonstrated that adenovirus‐mediated ODC and AdoMetDC antisense expression inhibits tumor cell growth through a blockade of the polyamine synthesis pathway. This inhibitory effect cannot be reversed by the administration of putrescine. Tumor cells were arrested at the G~1~ phase of the cell cycle after gene transfer and had reduced invasiveness. The adenovirus also induced tumor regression in established tumors in nude mice.
Conclusions
Our study suggests that Ad‐ODC‐AdoMetDCas has antitumor activity and therapeutic potential for the treatment of colorectal cancer. Copyright © 2006 John Wiley & Sons, Ltd.